Videos by CD Bioparticles in New York. CD Bioparticles is an established drug delivery company which provides customized solutions for developing and producing new, biocompatible drug delivery systems.
Probiotic-based therapy holds promise as a potential approach to treat gut microbiota dysbiosis, but oral bioavailability and therapeutic efficacy still limit the development of this strategy. Here, researchers propose a simple and safe strategy for the treatment of colitis by nanoencapsulating the probiotic and anti-inflammatory agent 5-aminosalicylic acid (5-ASA) in gastrointestinal microenvironment-responsive alginate polysaccharides.
https://www.cd-bioparticles.net/alginates
Probiotic-based therapy holds promise as a potential approach to treat gut microbiota dysbiosis, but oral bioavailability and therapeutic efficacy still limit the development of this strategy. Here, researchers propose a simple and safe strategy for the treatment of colitis by nanoencapsulating the probiotic and anti-inflammatory agent 5-aminosalicylic acid (5-ASA) in gastrointestinal microenvironment-responsive alginate polysaccharides. https://www.cd-bioparticles.net/alginates